LIGAND PHARMACEUTICALS INC Annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Ligand Pharmaceuticals Inc quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from 2010 to 2023.
  • Ligand Pharmaceuticals Inc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending September 30, 2024 was -$4.49M, a 56.2% increase year-over-year.
  • Ligand Pharmaceuticals Inc Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending September 30, 2024 was $47.9M, a 189% increase year-over-year.
  • Ligand Pharmaceuticals Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was $52.3M.
  • Ligand Pharmaceuticals Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was -$33.4M, a 159% decline from 2021.
  • Ligand Pharmaceuticals Inc annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was $57M.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Annual (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $52.3M +$85.7M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$33.4M -$90.5M -159% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $57M +$60.6M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$3.57M -$634M -101% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $630M +$488M +342% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $142M +$130M +1058% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $12.3M +$16.1M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$3.8M -$234M -102% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $230M +$216M +1534% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $14.1M -$271K -1.89% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-28
2013 $14.3M +$14.9M Jan 1, 2013 Dec 31, 2013 10-K/A 2016-11-15
2012 -$527K -$10.2M -105% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-23
2011 $9.68M +$20.5M Jan 1, 2011 Dec 31, 2011 10-K/A 2014-12-12
2010 -$10.9M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.